Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$66.35 USD
-0.28 (-0.42%)
Updated May 17, 2024 04:00 PM ET
After-Market: $66.38 +0.03 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACHC 66.35 -0.28(-0.42%)
Will ACHC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ACHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACHC
Acadia (ACHC), Geisinger JV Begin Construction of New Hospital
Acadia Healthcare (ACHC) Shares Down 9% Despite Q1 Earnings Beat
ACHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acadia Healthcare (ACHC) Q1 Earnings Surpass Estimates
Tenet Healthcare (THC) Q1 Earnings and Revenues Top Estimates
Acadia Healthcare (ACHC) Opens Facility to Address Mental Health
Other News for ACHC
Assessing Acadia Healthcare Co: Insights From 12 Financial Analysts
Acadia Healthcare price target lowered by $10 at TD Cowen, here's why
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)
Acadia Healthcare price target lowered by $2 at Barclays, here's why